A common pharmacophore for cytotoxic natural products that stabilize microtubules

Iwao Ojima, Subrata Chakravarty, Tadashi Inoue, Songnian Lin, Lifeng He, Susan Band Horwitz, Scott D. Kuduk, Samuel J. Danishefsky

Research output: Contribution to journalArticle

269 Citations (Scopus)

Abstract

Taxol (paclitaxel), a complex diterpene obtained from the Pacific yew, Taxus brevifolia, is arguably the most important new drug in cancer chemotherapy. The mechanism of cytotoxic action for paclitaxel - i.e., the stabilization of microtubules leading to mitotic arrest - is now shared by four recently identified natural products, eleutherobin, epothilones A and B, and discodermolide. Their ability to competitively inhibit [3H]paclitaxel binding to microtubules strongly suggests the existence of a common binding site. Recently, we have developed nonaromatic analogues of paclitaxel that maintain high cytotoxicity and tubulin binding (e.g., nonataxel). We now propose a common pharmacophore that unites paclitaxel, nonataxel, the epothilones, eleutherobin, and discodermolide, and rationalizes the extensive structure-activity relationship data pertinent to these compounds. Insights from the common pharmacophore have enabled the development of a hybrid construct with demonstrated cytotoxic and tubulin-binding activity.

Original languageEnglish (US)
Pages (from-to)4256-4261
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume96
Issue number8
DOIs
StatePublished - Apr 13 1999

Fingerprint

Paclitaxel
Biological Products
Microtubules
Tubulin
Epothilones
Taxus
Diterpenes
Structure-Activity Relationship
Binding Sites
Drug Therapy
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

A common pharmacophore for cytotoxic natural products that stabilize microtubules. / Ojima, Iwao; Chakravarty, Subrata; Inoue, Tadashi; Lin, Songnian; He, Lifeng; Band Horwitz, Susan; Kuduk, Scott D.; Danishefsky, Samuel J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 8, 13.04.1999, p. 4256-4261.

Research output: Contribution to journalArticle

Ojima, Iwao ; Chakravarty, Subrata ; Inoue, Tadashi ; Lin, Songnian ; He, Lifeng ; Band Horwitz, Susan ; Kuduk, Scott D. ; Danishefsky, Samuel J. / A common pharmacophore for cytotoxic natural products that stabilize microtubules. In: Proceedings of the National Academy of Sciences of the United States of America. 1999 ; Vol. 96, No. 8. pp. 4256-4261.
@article{6e97cf3c730d488b899f3b5420c560b5,
title = "A common pharmacophore for cytotoxic natural products that stabilize microtubules",
abstract = "Taxol (paclitaxel), a complex diterpene obtained from the Pacific yew, Taxus brevifolia, is arguably the most important new drug in cancer chemotherapy. The mechanism of cytotoxic action for paclitaxel - i.e., the stabilization of microtubules leading to mitotic arrest - is now shared by four recently identified natural products, eleutherobin, epothilones A and B, and discodermolide. Their ability to competitively inhibit [3H]paclitaxel binding to microtubules strongly suggests the existence of a common binding site. Recently, we have developed nonaromatic analogues of paclitaxel that maintain high cytotoxicity and tubulin binding (e.g., nonataxel). We now propose a common pharmacophore that unites paclitaxel, nonataxel, the epothilones, eleutherobin, and discodermolide, and rationalizes the extensive structure-activity relationship data pertinent to these compounds. Insights from the common pharmacophore have enabled the development of a hybrid construct with demonstrated cytotoxic and tubulin-binding activity.",
author = "Iwao Ojima and Subrata Chakravarty and Tadashi Inoue and Songnian Lin and Lifeng He and {Band Horwitz}, Susan and Kuduk, {Scott D.} and Danishefsky, {Samuel J.}",
year = "1999",
month = "4",
day = "13",
doi = "10.1073/pnas.96.8.4256",
language = "English (US)",
volume = "96",
pages = "4256--4261",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8",

}

TY - JOUR

T1 - A common pharmacophore for cytotoxic natural products that stabilize microtubules

AU - Ojima, Iwao

AU - Chakravarty, Subrata

AU - Inoue, Tadashi

AU - Lin, Songnian

AU - He, Lifeng

AU - Band Horwitz, Susan

AU - Kuduk, Scott D.

AU - Danishefsky, Samuel J.

PY - 1999/4/13

Y1 - 1999/4/13

N2 - Taxol (paclitaxel), a complex diterpene obtained from the Pacific yew, Taxus brevifolia, is arguably the most important new drug in cancer chemotherapy. The mechanism of cytotoxic action for paclitaxel - i.e., the stabilization of microtubules leading to mitotic arrest - is now shared by four recently identified natural products, eleutherobin, epothilones A and B, and discodermolide. Their ability to competitively inhibit [3H]paclitaxel binding to microtubules strongly suggests the existence of a common binding site. Recently, we have developed nonaromatic analogues of paclitaxel that maintain high cytotoxicity and tubulin binding (e.g., nonataxel). We now propose a common pharmacophore that unites paclitaxel, nonataxel, the epothilones, eleutherobin, and discodermolide, and rationalizes the extensive structure-activity relationship data pertinent to these compounds. Insights from the common pharmacophore have enabled the development of a hybrid construct with demonstrated cytotoxic and tubulin-binding activity.

AB - Taxol (paclitaxel), a complex diterpene obtained from the Pacific yew, Taxus brevifolia, is arguably the most important new drug in cancer chemotherapy. The mechanism of cytotoxic action for paclitaxel - i.e., the stabilization of microtubules leading to mitotic arrest - is now shared by four recently identified natural products, eleutherobin, epothilones A and B, and discodermolide. Their ability to competitively inhibit [3H]paclitaxel binding to microtubules strongly suggests the existence of a common binding site. Recently, we have developed nonaromatic analogues of paclitaxel that maintain high cytotoxicity and tubulin binding (e.g., nonataxel). We now propose a common pharmacophore that unites paclitaxel, nonataxel, the epothilones, eleutherobin, and discodermolide, and rationalizes the extensive structure-activity relationship data pertinent to these compounds. Insights from the common pharmacophore have enabled the development of a hybrid construct with demonstrated cytotoxic and tubulin-binding activity.

UR - http://www.scopus.com/inward/record.url?scp=0033551046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033551046&partnerID=8YFLogxK

U2 - 10.1073/pnas.96.8.4256

DO - 10.1073/pnas.96.8.4256

M3 - Article

C2 - 10200249

AN - SCOPUS:0033551046

VL - 96

SP - 4256

EP - 4261

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8

ER -